WebBENLYSTA is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines. BENLYSTA is also known by its generic name, belimumab. It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system ... WebApr 1, 2024 · Benlysta; Descriptions. Belimumab injection is used to treat active, autoantibody-positive, systemic lupus erythematosus (SLE) and active lupus nephritis in patients who are also receiving other lupus treatments. It is a monoclonal antibody that changes the immune system to help control lupus symptoms.
Side Effects of Benlysta (Belimumab), Warnings, Uses - RxList
WebBenlysta(belimumab) is a human monoclonal antibody drug that specifically recognizes and inhibits the biological activity of B lymphocytestimulator, or BLyS. BLyS is a cytokinethat belongs to the tumor necrosis factor (TNF) ligandfamily. It is expressedas transmembraneprotein on various cell types ... WebJul 1, 2014 · Benlysta belongs to a group of drugs called monoclonal antibodies, which target, bind to, and limit the activity of certain proteins involved in disease processes. In lupus, a protein known as BLyS helps drive the activity of immune cells called B-cells. B-cells play a role in the inflammatory responses associated with lupus. farmácia drogasil janga telefone
Benlysta (Belimumab): Uses, Dosage, Side Effects, Interactions ... - RxList
Web1-877-4-BENLYSTA (1-877-423-6597)Monday to Friday, 8 AM to 8 PM, ETSelect option 1 for BENLYSTA Gateway. www.benlystagatewayonline.com. Download BENLYSTA Gateway Enrollment Form (English) BENLYSTA Gateway Brochure (English) WebApr 1, 2012 · BAFF is the target of the drug belimumab (Benlysta, GSK), which was approved by the Food and Drug Administration in 2011, making it the first drug in 52 … WebDec 17, 2024 · About BENLYSTA (belimumab) BENLYSTA, a BLyS-specific inhibitor, is a human monoclonal antibody that binds to soluble BLyS. BENLYSTA does not bind B cells directly. By binding BLyS, BENLYSTA inhibits the survival of B cells, including autoreactive B cells, and reduces the differentiation of B cells into immunoglobulin-producing plasma … hnl manual